Medicinal prices in 2027: drugs costing up to five euros may rise 2.3%, and essential ones will not decrease
The government has set new rules for 2027 drug pricing to ensure market availability. Medicines priced at or below five euros may see a 2.3% price increase, while essential and critical drugs, as well as generics and biosimilars, are exempt from the annual price review that typically triggers decreases. Additionally, brand-name and non-biological drugs priced at or below 20 euros (for pharmacies) or 75 euros (for hospital use) are also exempt from the annual revision.

